Sri Lanka Telecom PLC (SLTL.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Sri Lanka Telecom PLC (SLT) is a Information and Communications Technology (ICT) solutions provider, involved in providing broadband and backbone infrastructure services. The company offers a range of ICT facilities and services, including voice, data, broadband, wholesale, enterprise, TV, and mobile services. Its major products include network and national backbone network, ADSL2+, VDSL2, optical fibre, carrier-grade Wi-Fi, and both fixed and mobile 4G LTE technologies. SLT serves a diverse customer base, including multinational corporations, large and small corporate, public sector, retail, and domestic customers The company operates through its own distribution networks and multiple international submarine cable systems. SLT operates primarily in Sri Lanka and is headquartered in Colombo, Sri Lanka.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Faes Farma SA - Key Facts
Faes Farma SA - Key Employees
Faes Farma SA - Key Employee Biographies
Faes Farma SA - Major Products and Services
Faes Farma SA - History
Faes Farma SA - Company Statement
Faes Farma SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Faes Farma SA - Business Description
Business Segment: Animal Nutrition and Health
Overview
Performance
Business Segment: Pharmaceutical and Healthcare Specialties
Overview
Performance
Business Segment: Pharmaceutical Raw Materials
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: International
Performance
R&D Overview
Faes Farma SA - Corporate Strategy
Faes Farma SA - SWOT Analysis
SWOT Analysis - Overview
Faes Farma SA - Strengths
Faes Farma SA - Weaknesses
Faes Farma SA - Opportunities
Faes Farma SA - Threats
Faes Farma SA - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Faes Farma SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
Apr 30, 2026: Faes Farma Exceeds 200 Million in Revenue (31%) and Increases Net Profit by 9% in First Quarter
Nov 04, 2025: Faes Farma Reports 15% Revenue Growth to €454 Million
Jul 30, 2025: Faes Farma appoints Isabel Nájera as Chief Scientific Officer and member of the Global Executive Team
Jul 24, 2025: Faes Farma Increases Revenues 12.3% to 307.4 Million Euros
Apr 21, 2025: Faes Farma Hires Isabel Najera as Chief Scientific Officer and Member of the Global Executive Team.
Apr 01, 2025: CIC bioGUNE Receives the Development and Innovation Management team from FAES Farma
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
Faes Farma SA, Key Facts
Faes Farma SA, Key Employees
Faes Farma SA, Key Employee Biographies
Faes Farma SA, Major Products and Services
Faes Farma SA, History
Faes Farma SA, Subsidiaries
Faes Farma SA, Key Competitors
Faes Farma SA, Ratios based on current share price
Faes Farma SA, Annual Ratios
Faes Farma SA, Interim Ratios
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Faes Farma SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Faes Farma SA, Performance Chart (2021 - 2025)
Faes Farma SA, Ratio Charts
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net